Denise Steiner

Dr. Denise Steiner

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
KGKatrin Göke
Katrin Göke
TLThomas Lorenz
Thomas Lorenz
ARAlexandros Repanas
Alexandros Repanas
FSFrederic Schneider
Frederic Schneider
DSDenise Steiner
Denise Steiner
Arno KwadeArno Kwade
Arno Kwade

1 November 2011 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
SRSereina Riniker
Sereina Riniker
CCClara D. Christ
Clara D. Christ
HHHalvor S. Hansen
Halvor S. Hansen
PHPhilippe H. Hünenberger
Philippe H. Hünenberger
COChris Oostenbrink
Chris Oostenbrink
WGWilfred F. van Gunsteren
Wilfred F. van Gunsteren

9 December 2018 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
MCMariana Morais Tavares Colferai
Mariana Morais Tavares Colferai
GMGabriela Momente Miquelin
Gabriela Momente Miquelin
DSDenise Steiner
Denise Steiner

1 September 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
DSDenise Steiner
Denise Steiner
Jan Henrik FinkeJan Henrik Finke
Jan Henrik Finke
Arno KwadeArno Kwade
Arno Kwade

15 May 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DSDenise Steiner
Denise Steiner
AMAlexander Meyer
Alexander Meyer
LILaura Isabell Immohr
Laura Isabell Immohr
MPMiriam Pein
Miriam Pein
In this review, we aim to highlight the advantages, challenges, and limitations of electronic tongues (e-tongues) in pharmaceutical drug development. The authors, therefore, critically evaluated the performance of e-tongues regarding their qualification to assess peroral formulations containing bitter active pharmaceutical ingredients. A literature search using the keywords ‘electronic’, ‘tongue’, ‘bitter’, and ‘drug’ in a Web of Science search was therefore initially conducted. Reviewing the publications of the past decade, and further literature where necessary, allowed the authors to discuss whether and how e-tongues perform as expected and whether they have the potential to become a standard tool in drug development. Specifically highlighted are the expectations an e-tongue should meet. Further, a brief insight into the technologies of the utilized e-tongues is given. Reliable protocols were found that enable (i) the qualified performance of e-tongue instruments from an analytical perspective, (ii) proper taste-masking assessments, and (iii) under certain circumstances, the evaluation of bitterness.

25 October 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JKJonas Klaus Koehler
Jonas Klaus Koehler
SSStefanie Schmager
Stefanie Schmager
VBValentin Bender
Valentin Bender
DSDenise Steiner
Denise Steiner
UMUlrich Massing
Ulrich Massing
Dual centrifugation (DC) is an innovative in-vial homogenization and in-vial nanomilling technique that has been in use for the preparation of liposomes for more than one decade. Since then, DC has continuously been developed for preparing various liposomes and other lipid nanoparticles including emulsions and solid lipid nanoparticles (SLNs) as well as polymersomes and nanocrystals. Improvements in equipment technology have been achieved over the past decade, so that DC is now on its way to becoming the quasi-standard for the simple, fast, and aseptic production of lipid nanoparticles and nanocrystals in small and medium batch sizes, including the possibility of simple and fast formulation screening or bedside preparations of therapeutic nanoparticles. More than 68 publications in which DC was used to produce nanoparticles have appeared since then, justifying an initial review of the use of DC for pharmaceutical nanotechnology.